People · Operator
Named in public records as an officer, director or promoter · active 2013–2017 · Other Health Care, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| USDS, Inc. | — | Other Health Care | Series A | $6.1M | $92.4M | 2013 |
| Indi Molecular, Inc. | — | Biotechnology | Series A | $4.5M | $161.8M | 2017 |
Douglas Fisher at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Douglas Fisher on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Arnold Oronsky | 1 | 10 |
| Stephen Davis | 1 | 8 |
| Leroy Hood | 1 | 5 |
| James Heath | 1 | 5 |
| Mark McClellan | 1 | 3 |
| Doug Fisher | 1 | 3 |
| Alan Mendelson | 1 | 3 |
| Andreas Jurgeit | 1 | 2 |
| Albert Luderer | 1 | 2 |
| Heather Agnew | 1 | 1 |
| Darren Cai | 1 | 1 |
| Robert Flaherty | 1 | 1 |
| Maryellen De Mars | 1 | 1 |
| Christopher Singer | 1 | 1 |
| Jeffrey Cossman | 1 | 1 |
| Robert Lechleider | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.